Id. Krantz et al., DELETIONS OF 20P12 IN ALAGILLE-SYNDROME - FREQUENCY AND MOLECULAR CHARACTERIZATION, American journal of medical genetics, 70(1), 1997, pp. 80-86
Alagille syndrome is an autosomal dominant disorder comprising cholest
asis (associated with intrahepatic bile duct paucity), characteristic
facial appearance, and cardiac, ocular and skeletal defects, Multiple
patients have been reported with deletions or translocation involving
20p11.23-p12, providing evidence for the localization of the disease g
ene to this region. Fifty-six Alagille syndrome patients have been stu
died by cytogenetic and/or molecular analysis to determine the frequen
cy of detectable abnormalities of 20p12. Two of fifty-six patients stu
died by cytogenetic analysis had abnormalities: an interstitial deleti
on in one patient and a translocation in another. Of forty-five patien
ts studied by molecular analysis, three were found to have deletions o
f 20p, including the two patients identified with cytogenetic abnormal
ities. Molecular and molecular cytogenetic (FISH) analysis of the tran
slocation (46,XX,t(2;20)(q21.3p12)) demonstrated a deletion at the tra
nslocation breakpoint, The deletions identified in the three patients
are overlapping, contributing to the delineation of an Alagille syndro
me critical region within 20p12. This region lies between markers D20S
41 and D20S162. The frequency of detectable cytogenetic abnormalities
of 20p12 in this group of Alagille patients is 2/56 (3.6%), and the fr
equency of molecular deletions is 3/45 (6.7%). This is considerably lo
wer than the frequency of deletions observed in contiguous gene deleti
on syndromes suggesting that Alagille syndrome may be caused by the al
teration of a single gene. (C) 1997 Wiley-Liss, Inc.